The liver expression of FABP4 was reduced in the absence of cathepsin B, a cysteine protease found to be upregulated in the livers of MASH mice, supporting its role as an active player in the disease [125]. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.